Showing results (511-520 of 1,074) with videos related to
Sort By:
Pageof 108
Therapeutic Advances in Neurological Disorders|August 10, 2026
Relapse risk and functional outcomes in anti-LGI1 encephalitis: A multicenter retrospective analysisChun-Hong Shen, Bo Jin, Ye Du, et al.Therapeutic Advances in Neurological Disorders|September 10, 2026
Use of subcutaneous natalizumab in routine care - Final results of a non-interventional, observational study (SISTER) in Germany and AustriaRalf Gold, Stephan Schmidt, Florian Deisenhammer, et al.Therapeutic Advances in Neurological Disorders|September 13, 2026
Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional studyYue Yu, Yuxin Fan, Han Bao, et al.Therapeutic Advances in Neurological Disorders|April 5, 2019
An update on best practice of deep brain stimulation in Parkinson's diseaseChristian J Hartmann, Sabine Fliegen, Stefan J Groiss, et al.Therapeutic Advances in Neurological Disorders|March 30, 2019
Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson's diseaseLaura Pelizzari, Maria Marcella Laganà, Federica Rossetto, et al.Therapeutic Advances in Neurological Disorders|March 20, 2019
Relative health-related quality of life after treatment of unruptured intracranial aneurysms: long-term outcomes and influencing factorsPhilipp Dammann, Paula Wittek, Marvin Darkwah Oppong, et al.Therapeutic Advances in Neurological Disorders|August 28, 2019
B cell depletion can be effective in multiple sclerosis but failed in a patient with advanced childhood cerebral X-linked adrenoleukodystrophyHendrik Rosewich, Stefan Nessler, Wolfgang Brück, et al.Therapeutic Advances in Neurological Disorders|September 14, 2019
Stroke-related complications in large hemisphere infarction: incidence and influence on unfavorable outcomeJie Li, Ping Zhang, Simiao Wu, et al.Therapeutic Advances in Neurological Disorders|January 6, 2022
Advances and challenges in the treatment of myasthenia gravisChristiane Schneider-Gold, Nils Erik GilhusTherapeutic Advances in Neurological Disorders|March 22, 2012
Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?Ulrik Dalgas, Egon StenagerPageof 108